Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients

Laryngoscope - Tập 108 Số 10 - Trang 1435-1441 - 1998
Andrew Blitzer1,2, Mitchell F. Brin3,1,2, Celia Stewart4,1
1New York Center for Voice and Swallowing Disorders, New York University, New York, New York
2The Head and Neck Surgical Group, LLC, New York, New York
3Department of Speech-Language Pathology and Audiology, New York University, New York, New York
4Department of Neurology, Mt. Sinai School of Medicine, New York University, New York, New York

Tóm tắt

AbstractObjectives: This paper reviews a 12‐year experience in more than 900 patients with spasmodic dysphonia who have been treated with botulinum toxin. Study Design: This is a retrospective analysis of patients with adductor spasmodic dysphonia (strainstrangled voice), abductor spasmodic dysphonia (whispering voice), and adductor breathing dystonia (paradoxical vocal fold motion), all of whom have been treated with botulinum toxin injections for relief of symptom. Methods: All of the patients were studied with a complete head and neck and neurologic examination; fiberoptic laryngostroboscopy; acoustic and aerodynamic measures; and a speech evaluation including the Universal spasmodic dysphonia rating scale. Some were given electromyography. All patients received botulinum toxin injections into the affected muscles under electromyographic guidance. Results: The adductor patients had an average benefit of 90% of normal function lasting an average of 15.1 weeks. The abductor patients had an average benefit of 66.7% of normal function lasting an average of 10.5 weeks. Adverse effects included mild breathiness and coughing on fluids in the adductor patients, and mild stridor in a few of the abductor patients. Conclusion: Botulinum toxin A injection of the laryngeal hyperfunctional muscles has been found over the past 12 years to be the treatment of choice to control the dystonic symptoms in most patients with spasmodic dysphonia. Laryngoscope, 108:1435–1441, 1998

Từ khóa


Tài liệu tham khảo

10.1288/00005537-198802000-00015

Brin MF, 1992, Neurological Disorders of the Larynx, 240

10.1177/000348949110000201

10.1016/0021-9924(81)90037-X

10.1288/00005537-199401000-00007

10.1378/chest.107.5.1309

10.1044/jshd.3303.219

10.1177/019459988409200105

10.1177/000348948509400614

10.1212/WNL.32.10.1202

10.1093/brain/108.2.463

10.1212/WNL.38.5.702

10.1002/ana.410270203

10.1002/ana.410290203

Fahn S, 1988, X‐linked recessive dystonia and parkinsonism in Filipino males [abstract], Ann Neurol, 24, 179

10.1212/WNL.40.9.1438

10.1212/WNL.41.2_Part_1.174

Ozelius LJ, 1992, Strong allelic association between the tortion dystonia gene (DTY1) and loci on chromosome 9q34 in Ashkenazi Jews, Am J Human Genet, 50, 619

10.1002/ana.410360514

10.1212/WNL.44.2.283

10.1002/ana.410270203

10.1038/ng1194-236

10.1016/B978-0-12-644445-2.50026-X

Binz T, 1994, Proteolysis of SNAP‐25 by types E and A botulinal neurotoxins, J Biol Chem, 269, 1617, 10.1016/S0021-9258(17)42071-0

10.1001/archotol.1987.01860060029009

10.1212/WNL.38.8.1220

10.1177/019459989010300515

10.1177/019459989411100615

Koufman JA, 1992, New classification of laryngeal dystonias, The Visible Voice, 1, 1

10.1007/978-1-4899-2903-7

10.1288/00005537-198309000-00015

Darley FL, 1975, Motor Speech Disorders, 25

10.1044/jshd.5102.125

Aronson AE, 1985, Clinical Voice Disorders, 5

10.1288/00005537-199202000-00011

10.1177/019459989110400614

Thông tin
Thông tin xuất bản

Laryngoscope

Tập 108 Số 10

1435-1441

Thông tin tác giả